http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104628671-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159936a9a847e1b85fb4d921ae15d764 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcb4ce2c07706533757f51b0f91eaf8 |
| publicationDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104628671-A |
| titleOfInvention | Nitrobenzothiazole carboxylic acid amide compound containing phenylamidine structure and application |
| abstract | The invention relates to the field of medicine related to type 2 diabetes. Specifically, the present invention relates to a nitrobenzothiazole carboxylic acid amide non-glycoside SGLT2/SGLT1 dual-target inhibitor containing a phenylamidine structure, its preparation method and its application in the preparation of type 2 diabetes drugs. |
| priorityDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.